Provided by Tiger Trade Technology Pte. Ltd.

JUNSHI BIO

17.530
-0.930-5.04%
Volume:2.51M
Turnover:44.40M
Market Cap:18.00B
PE:-20.15
High:18.300
Open:18.300
Low:17.420
Close:18.460
52wk High:38.640
52wk Low:15.250
Shares:1.03B
HK Float Shares:260.00M
Volume Ratio:1.41
T/O Rate:0.96%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.870
ROE:-9.32%
ROA:-2.23%
PB:2.60
PE(LYR):-20.15
PS:5.10

Loading ...

BRIEF-Shanghai Junshi Biosciences Posts Quarterly Net Loss Attributable RMB20.6 Million

Reuters
·
Apr 27

Shanghai Junshi Biosciences - Qtrly Operating Income RMB726.3 Mln

THOMSON REUTERS
·
Apr 27

Junshi Bio Proposes Adoption of 2026 A-Share Employee Stock Ownership Scheme

Stock News
·
Apr 27

Junshi Bio Board Clears Q1-2026 Report and Unveils New A-Share Employee Stock Ownership Plan

Bulletin Express
·
Apr 27

君实生物2025年收入接近25亿元 核心管线拓展助力亏损明显收窄

Bulletin Express
·
Apr 27

Daily Stake Changes for April 23: Four Firms Including Junshi Bio Plan Reductions, Guochuang Hi-Tech Announces Increase (Table)

Deep News
·
Apr 23

Junshi Bio: Shanghai Tanying Targets ≤2% Block Trade Exit; Ex-Director’s Spouse Plans Minor Sell-Down

Bulletin Express
·
Apr 23

Shanghai Junshi Biosciences -Shanghai Tanying Plans to Reduce Its Holdings of Co's Shares by No More Than 20.5 Mln Shares Through Block Trading

THOMSON REUTERS
·
Apr 23

BNP PARIBAS SA Reduces Stake in Junshi Bio by 510,200 Shares at HK$27.6 Each

Stock News
·
Apr 23

BNP PARIBAS SA Reduces Stake in Junshi Bio by 1.126 Million Shares at HK$26.31 Each

Stock News
·
Apr 20

Stock Track | Junshi Biosciences Soars 5.11% Intraday on Positive Clinical Data and Broker Upgrade

Stock Track
·
Apr 20

Stock Track | Junshi Bio Soars 5.01% Intraday on Anticipation of AACR Clinical Data for JS207 and JS212

Stock Track
·
Apr 17

Junshi Bio Shares Climb Over 3% Again as Investors Await AACR Data on JS207 and JS212

Stock News
·
Apr 17

Junshi Biosciences Sets 27 Apr 2026 Board Meeting to Review Q1 2026 Unaudited Results

Bulletin Express
·
Apr 15

Stock Track | Junshi Biosciences Soars 5.43% Intraday on Shareholder Confidence and Strong Revenue Growth

Stock Track
·
Apr 15

BNP PARIBAS SA Reduces Stake in Junshi Bio by 1.19 Million Shares at HK$26.18 Each

Stock News
·
Apr 14

Stock Track | Junshi Biosciences Soars 8.66% Intraday as Major Shareholder Holds Stake After Sale Plan Lapses

Stock Track
·
Apr 13

Junshi Biosciences' Shareholder Keeps Stake After Sale Plan Lapses; Shares Jump 5%

MT Newswires Live
·
Apr 13

Junshi Bio: 2% Share-Sale Plan by 5%+ Shareholder Expires Without Execution

Bulletin Express
·
Apr 10

JUNSHI BIO (01877) Announces Shareholder Shanghai Tanying Did Not Reduce Holdings

Stock News
·
Apr 10